Abstract:Substrate specificity of protein kinases is of fundamental importance for the integrity and fidelity of signaling pathways. Glycogen synthase Kinase 3 beta (GSK3 beta) has a unique substrate specificity that prefers phosphorylation of its substrates at the P+4 serine before it can further phosphorylate the substrate at the PO serine in the canonical motif SXXXS-(p), where S(p) is the primed phosphorylation site. The detailed phosphorylation mechanism, however, is not clearly understood. In this study, a three-dimensional (3D) model of the ternary complex of GSK3 beta, ATP, and the phosphorylated glycogen synthase (pGS), termed GSK3 beta/ATP/pGS, is constructed using a hierarchical approach and by integrating molecular modeling and molecular dynamics (MD) simulations. Based on the 3D model, the substrate primed phosphorylation mechanism is investigated via two 12 ns comparative MD simulations of the GSK3 beta/ATP/pGS and GSK3 beta/ATP/GS systems, which differ in the phosphate group bound to the P+4 serine of GS. In agreement with structural analysis, computed binding free energies reveal that the binding of pGS to GSK3 beta is favored in the prephosphorylated state compared with the GS native state. More importantly, comparison with the system simulated without primed phosphorylation in the GSK3 beta/ATP/GS complex shows that for an optimal phosphorylation reaction to occur, the pGS priming phosphate in the GSK3 beta/ATP/pGS system optimizes the proper orientation of the GSK3 beta N- and C-terminal domains and clamps the P0 serine of pGS in the appropriate configuration for interaction with the ATP gamma-phosphate within the catalytic groove.

Delineating the active site architecture of G9a lysine methyltransferase through substrate and inhibitor binding mode analysis: a molecular dynamics study

The discovery of novel histone lysine methyltransferase G9a inhibitors (part 1): molecular design based on a series of substituted 2,4-diamino-7- aminoalkoxyquinazoline by molecular-docking-guided 3D quantitative structure-activity relationship studies.

Structural Simulation and Selective Inhibitor Discovery Study for Histone Demethylases KDM4E/6B from a Computational Perspective

G9a - an Appealing Antineoplastic Target

Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a

Structure-Based Design and Characterization of the Highly Potent and Selective Covalent Inhibitors Targeting the Lysine Methyltransferases G9a/GLP

Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines.

Mechanistic Exploration of Methionine 274 Acting As a "switch" of the Selective Pocket Involved in HDAC8 Inhibition: an in Silico Study

Discovery of A 2,4-Diamino-7-aminoalkoxyquinazoline As A Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a

Molecular modeling and molecular dynamics simulation studies of the GSK3β/ATP/substrate complex: understanding the unique P+4 primed phosphorylation specificity for GSK3β substrates.

Structural Biology of Human H3K9 Methyltransferases

Exploring the Mechanism How AF9 Recognizes and Binds H3K9ac by Molecular Dynamics Simulations and Free Energy Calculations.

Discovery and development of potent and selective inhibitors of histone methyltransferase g9a.

Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation

Homology modeling, force field design, and free energy simulation studies to optimize the activities of histone deacetylase inhibitors

Origins of Catalysis in Non‐Heme Fe(II)/2‐Oxoglutarate‐Dependent Histone Lysine Demethylase KDM4A with Differently Methylated Histone H3 Peptides

Research Progress in Inhibitors of Histone Methyltransferase G9a

Insight into the Selective Binding Mechanism of DNMT1 and DNMT3A Inhibitors: a Molecular Simulation Study.

Detailed Exploration Around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces.

Discovery, Design and Synthesis of 6H-Anthra[1,9-cd]isoxazol-6-one Scaffold As G9a Inhibitor Through a Combination of Shape-Based Virtual Screening and Structure-Based Molecular Modification

Structural Studies Provide New Insights into the Role of Lysine Acetylation on Substrate Recognition by CARM1 and Inform the Design of Potent Peptidomimetic Inhibitors